SCHEMBL20437450

SCHEMBL20437450

N#Cc1cc(-n2c3ccccc3c3cc(-c4ccccc4)ccc32)c(-n2c3ccccc3c3cc(-c4ccccc4)ccc32)cc1-c1cc(-n2c3ccccc3c3cc(-c4ccccc4)ccc32)c(-n2c3ccccc3c3cc(-c4ccccc4)ccc32)cc1C#N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSPO P30536 1/20 0.38
NPSR1 Q6W5P4 2/20 0.36
MAOA P21397 2/20 0.36
MAOB P27338 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALDH1A1 P00352 4/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
IMPDH2 P12268 1/20 0.35
MCL1 Q07820 1/20 0.35
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
KDM4E B2RXH2 3/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HTT P42858 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20437453 0.93 TSPO (0.39) TSPONPSR1MAOAMAOBCYP1A2
SCHEMBL25138565 0.93 MAOA (0.41) TSPONPSR1MAOAMAOBALDH1A1
SCHEMBL19943062 0.90 NPSR1 (0.34) TSPONPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL19909143 0.89 PIK3CA (0.41) NPSR1CYP1A2CYP2C9CYP2C19CYP11B1
SCHEMBL22156577 0.89 CYP11B1 (0.36) TSPONPSR1MAOAMAOBCYP1A2
SCHEMBL22760718 0.89 ALDH1A3 (0.40) CYP1A2CYP2C9CYP2C19ALDH1A1KDM4E
SCHEMBL22563491 0.89 SQOR (0.36) NPSR1CYP1A2CYP2C9CYP2C19CYP11B1
SCHEMBL19909358 0.89 MYC (0.37) NPSR1CYP1A2CYP2C9CYP2C19CYP11B1
SCHEMBL22158513 0.89 CYP11B1 (0.36) TSPOCYP11B1CYP11B2
SCHEMBL20617280 0.89 TRPA1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180215711-A1 DOPANT FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-08-02 US disclosed
US-20180215711-A1 DOPANT FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180215711-A1 DOPANT FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD1, AOX1, AOC2 TSPO 2682/4885NPSR1 1015/4885MAOA 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.